CYTK vs HST · rev $28.6M vs P/E 16, rev $6.11B
Cytokinetics Inc (CYTK) versus Host Hotels & Resorts Inc (HST) — a side-by-side from cached financials, not a winner call.
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
Host Hotels & Resorts Inc (HST) is a reit - hotel & motel company listed on US.
Latest reported CYTK revenue for 2026-06-30 was $28.6M. Net income was -$198.8M. Revenue was up 47.9% from 2026-03-31 to 2026-06-30. CYTK currently screens at market cap $4.05B.
Latest reported HST revenue for 2025-12-31 was $6.11B. Net income was $765.0M. Revenue was up 7.6% from 2024-12-31 to 2025-12-31. HST currently screens at market cap $15.94B and trailing P/E 15.6.
CYTK currently screens at market cap $4.05B. HST currently screens at market cap $15.94B and trailing P/E 15.6.
Not investment advice. Open the CYTK and HST stock pages for the full models.
Not investment advice.